CareFusion Shipping Ventilators to CDC for National Emergency Preparedness

SAN DIEGO, Oct. 19  /PRNewswire-FirstCall/ -- CareFusion (NYSE:CFN), a leading, global medical device company, today announced it is shipping more than 3,900 CareFusion LTV® 1200 ventilators ordered by the Centers for Disease Control and Prevention (CDC) to be included in the strategic national stockpile.

The CDC ordered a total of 4,500 LTV® 1200 ventilators for the strategic national stockpile, which is the nation's reserve of medical products used in the event local supplies are depleted during a severe public health emergency, such as an earthquake, terrorist attack or influenza outbreak.

"Years of research and clinical input have gone into the development of the LTV 1200 to create a portable, easy-to-use ventilator that can adapt to a wide variety of circumstances," said David Schlotterbeck, chairman and CEO of CareFusion. "This is our largest order ever for this product and we are pleased to assist the CDC in the event of a national emergency."

CareFusion also previously supplied the State of California and the State of New York with LTV 1200 ventilators as part of their emergency preparedness programs.

The CDC and American Association of Respiratory Care have partnered to offer a webcast training module to show doctors and first responders how to best use the LTV 1200 in an emergency. The webcast also provides information on how to use the ventilator for patients with serious breathing problems caused by the H1N1 influenza virus. The webcast is available for download at: http://www.aarc.org/headlines/09/09/webcast_training.cfm.

About the CareFusion LTV 1200

The CareFusion LTV 1200 is an easy-to-use, versatile ventilator with infant to adult capabilities that is a fraction of the size of comparably equipped systems. It is designed to move seamlessly with the patient across a variety of settings ranging from transport to the emergency room to intensive care. The LTV 1200 also contains features that allow for flexible options (invasive or non-invasive ventilation) and enhanced monitoring to reliably observe patient safety during ventilation.

About CareFusion Corporation

CareFusion (NYSE:CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and Pulmonetic Systems ventilation and respiratory products, ChloraPrep® for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. More information may be found at http://www.carefusion.com/. 

DATASOURCE: CareFusion Corporation



CONTACT:  Media, Suzanne Hatcher, [phone],

, or Investors, Carol Cox, [phone],

, both of CareFusion Corporation; or Jeanne Beach,

[phone], , for CareFusion Corporation



Web Site:  http://www.carefusion.com/ 

Copyright